GENE ONLINE|News &
Opinion
Blog

CAR T-cell Therapy
In-Depth Cas9
CRISPR/Cas9 Gene Editing in Cell and Gene Therapies
2020-11-08
A Rising Star in Chinese Pharma Industry Marks Market Debut in Hong Kong
2020-10-29
In-Depth CRISPR
CRISPR Technology in Disease Modelling and Drug Discovery
2020-10-21
R&D CAR-T Technology
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
Asia-Pacific CAR T-cell Therapy
Takeda Established Capabilities to Engine Cell Therapy Manufacturing
2020-09-18
Trials & Approvals CAR T-cell Therapy
First and Only CAR T Therapy for Mantle Cell Lymphoma Gets FDA Nod
2020-07-30
R&D
Roche, Innovent Sign Billion Dollar Deal for Bispecific Antibodies
2020-06-11
Legend Biotech Closes Initial Public Offering Raising Big Money
2020-06-10
R&D
ASCO 2020: Celyad’s Off the Shelf CAR-T Cell Therapy Shows Promise against Colorectal Cancer
2020-06-07
Technology
What to Expect from the ASCO20 Virtual Program
2020-05-29
R&D Cancer
Gilead, Kite, and oNKo-innate Collaborate to Advance Cancer Immunotherapy Using NK Cells
2020-04-26
Trials & Approvals
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
R&D Acute Lymphoblastic Leukemia
11-year-old becomes the first recipient of Novartis’s personalized CAR-T therapy
2019-02-01
1 2 3 4
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top